This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA343233; GEO: GSE87021 |
| Type | Umbrella project |
| Publications | - Shaw B et al., "Molecular insights into an ancient form of Paget's disease of bone.", Proc Natl Acad Sci U S A, 2019 May 21;116(21):10463-10472
- Green D et al., "miR-16 is highly expressed in Paget's associated osteosarcoma.", Endocr Relat Cancer, 2017 May;24(5):L27-L31
|
| Submission | Registration date: 16-Sep-2016 Oxford Vaccine Group, Medical Sciences Division, University of Oxford |
| Relevance | Superseries |
Project Data:
| Resource Name | Number of Links |
|---|
| Sequence data |
| SRA Experiments | 12 |
| Publications |
| PubMed | 2 |
| PMC | 1 |
| Other datasets |
| BioSample | 12 |
| GEO DataSets | 3 |
Paget's associated osteosarcoma encompasses the following 2 sub-projects:
| Project Type | Number of Projects |
| Transcriptome or Gene expression | 2 |
BioProject accession | Organism | Title |
|---|
| PRJNA339449 | Homo sapiens | Endogenous tRNA fragments are expressed in a phosphaturic mesenchymal tumor and Paget's associated osteosarcoma (Norwich Medical School, University...) | | PRJNA343232 | Homo sapiens | Loss of miR-16 mediated silencing of SQSTM1 is associated with Paget's associated osteosarcoma (Oxford Vaccine Group, Medical...) |
|